These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2756515)

  • 1. [Efficacy and tolerability of cycletanine in aged patients with hypertension].
    Bodak A; Gavardin T; Salom M; Tarrade T; Forette F; Jungers P; Metellus J
    Therapie; 1989; 44(2):101-6. PubMed ID: 2756515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerance of cicletanine, a new antihypertensive agent: overview of 1226 treated patients.
    Tarrade T; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):205-14. PubMed ID: 3046884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of 2 dosages of a new antihypertensive agent, cicletanine, in elderly subjects].
    Jungers P; Gavardin T; Salom M; Tarrade T; Berthet P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():125-9. PubMed ID: 2514651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertension.
    Fodor GP; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):195-204. PubMed ID: 3046883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of cicletanine efficiency and tolerance in hypertensive patients treated with beta-blockaders].
    Clerson P; Deltour L; Billaut P; Tarrade T; Berthet P; Pauchant M
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1293-7. PubMed ID: 2573325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the optimal dose of the antihypertensive drug cicletanine hydrochloride in man.
    Guinot P; Jewitt-Harris J; Tarrade T
    Arzneimittelforschung; 1989 Jan; 39(1):86-9. PubMed ID: 2655611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effectiveness and tolerance of cicletanine in patients with essential hypertension treated with beta-blockers].
    Clerson P; Deltour L; Billaut P; Tarrade T; Berthet P; Pauchant M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():113-8. PubMed ID: 2575369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol].
    Forette F; Henry-Amar M; d'Allens H; Hervy MP; Bouchacourt P; Henry JF; Pappo M
    Ann Cardiol Angeiol (Paris); 1987 Feb; 36(2):103-7. PubMed ID: 3827157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dose-effectiveness relationship of cicletanine at short-term in moderately to severely hypertensive patients].
    Fritel D
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():99-102. PubMed ID: 2514676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of arterial hypertension in the aged with a calcium antagonist: nicardipine].
    Forette F; Bellet M; Henry JF; Hervy MP; Poyard-Salmeron C; Bouchacourt P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1242-6. PubMed ID: 6441544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of rhythm tolerance of cicletanine using continuous electrocardiographic recording].
    Witchitz S; Gryner S
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():145-9. PubMed ID: 2514655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.
    Angelino PF; Alvino-Demartino A; Mappa R; Donati C
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.